Across TCGA pan-cancer cohorts, LIN52 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LIN52 data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in brain lower grade glioma (LGG), where higher LIN52 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated LIN52 expression acts as an unfavorable survival marker.

LGG are the cancer types where LIN52 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Median	All	0.080	0.833	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: LIN52 tumor-vs-normal RNA expression · all LIN52 data types